Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Rabeprazole Dual Therapy vs Triple Therapy for H. pylori
NCT00197418Phase 3Unknown
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rabeprazole in Helicobacter pylori infection (2 arms), sponsored by Hamamatsu University School of Medicine. Primary endpoint: Re-eradication rate of H. pylori infection. Status: unknown.
02
Drugs
rabeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00197418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197418.